|
Synonyms: BMS-986458 | BMS986458
Compound class:
Synthetic organic
Comment: BMS-986458 is an orally bioavailable bifunctional degrader molecule that is designed to target the BCL6 transcription factor in B-cell lymphomas [1]. It promotes CRL4CRBN E3 ubiquitin ligase-dependent dagradation of the BCL6 protein. The chemical structure was disclosed during the 'First Time disclosures' session at the ACS Spring 2025 meeting in San Diego. This matches one of the compounds claimed in patent WO2023212147A1 [2]. The chemical structure was matched to that for the INN toviblideg, as disclosed in WHO INN Proposed List 135 (July 2026).
|
|
|||||||||||||||||||||||||||||||||||
| Selectivity at other protein targets | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||